Adiposity and Cancer: a Mendelian Randomization Analysis in the UK Biobank

Overview

Journal Int J Obes (Lond)

Specialty Endocrinology

Date 2021 Aug 28

PMID 34453097

Citations 11

Authors

Muktar Ahmed

Anwar Mulugeta

S Hong Lee

Ville-Petteri Makinen

Terry Boyle

Elina Hypponen

Affiliations

Soon will be listed here.

Abstract

Background: Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities.

Methods: We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either "unfavourable" (82 SNPs), "favourable" (24 SNPs) or "neutral" metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity.

Results: All genetic instruments had a strong association with BMI (p < 1 × 10 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer.

Conclusions: Higher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk.

Citing Articles

The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD.

Yan K, Wang Y, Xin P Int J Chron Obstruct Pulmon Dis. 2025; 20:245-257.

PMID: 39936140 PMC: 11812440. DOI: 10.2147/COPD.S495073.

Obesity, Physical Activity, and Cancer Incidence in Two Geographically Distinct Populations; The Gulf Cooperation Council Countries and the United Kingdom-A Systematic Review and Meta-Analysis.

Gaskell C, Lutimba S, Bendriss G, Aleem E Cancers (Basel). 2025; 16(24.

PMID: 39766104 PMC: 11674634. DOI: 10.3390/cancers16244205.

Relationships among gut microbiota, plasma metabolites, and juvenile idiopathic arthritis: a mediation Mendelian randomization study.

Gao B, Wang Z, Wang K, Lei Y, Zhuang Y, Zhou Z Front Microbiol. 2024; 15:1363776.

PMID: 38605717 PMC: 11007183. DOI: 10.3389/fmicb.2024.1363776.

Aminopeptidase O Protein mediates the association between and appendicular lean mass.

Gao B, Zhou Z, Chen J, Zhang S, Jin S, Yang W Front Microbiol. 2024; 15:1325466.

PMID: 38384268 PMC: 10879621. DOI: 10.3389/fmicb.2024.1325466.

The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study.

Yang J, Qu X, Zheng A, Jiang F, Chang H, Zhang J Sci Rep. 2024; 14(1):3478.

PMID: 38347022 PMC: 10861519. DOI: 10.1038/s41598-024-53926-z.

References

Coelho M, Oliveira T, Fernandes R . Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013; 9(2):191-200. PMC: 3648822. DOI: 10.5114/aoms.2013.33181. View

Deng T, Lyon C, Bergin S, Caligiuri M, Hsueh W . Obesity, Inflammation, and Cancer. Annu Rev Pathol. 2016; 11:421-49. DOI: 10.1146/annurev-pathol-012615-044359. View

Park J, Morley T, Kim M, Clegg D, Scherer P . Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014; 10(8):455-465. PMC: 4374431. DOI: 10.1038/nrendo.2014.94. View

Ittmann M, Huang J, Radaelli E, Martin P, Signoretti S, Sullivan R . Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res. 2013; 73(9):2718-36. PMC: 3644021. DOI: 10.1158/0008-5472.CAN-12-4213. View

Cozzo A, Fuller A, Makowski L . Contribution of Adipose Tissue to Development of Cancer. Compr Physiol. 2018; 8(1):237-282. PMC: 5806627. DOI: 10.1002/cphy.c170008. View

Plotnikov D, Guggenheim J . Mendelian randomisation and the goal of inferring causation from observational studies in the vision sciences. Ophthalmic Physiol Opt. 2019; 39(1):11-25. DOI: 10.1111/opo.12596. View

Guo Y, Andersen S, Shu X, Michailidou K, Bolla M, Wang Q . Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Med. 2016; 13(8):e1002105. PMC: 4995025. DOI: 10.1371/journal.pmed.1002105. View

Thrift A, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery M . Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015; 24(7):1024-31. PMC: 4490960. DOI: 10.1158/1055-9965.EPI-14-1309. View

Masuda T, Ogawa K, Kamatani Y, Murakami Y, Kimura T, Okada Y . A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese. Cancer Sci. 2020; 111(12):4646-4651. PMC: 7734162. DOI: 10.1111/cas.14667. View

11.

Dixon S, Nagle C, Thrift A, Pharoah P, Pearce C, Zheng W . Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. Int J Epidemiol. 2016; 45(3):884-95. PMC: 5644573. DOI: 10.1093/ije/dyw158. View

12.

Cornish A, Law P, Timofeeva M, Palin K, Farrington S, Palles C . Modifiable pathways for colorectal cancer: a mendelian randomisation analysis. Lancet Gastroenterol Hepatol. 2019; 5(1):55-62. PMC: 7026696. DOI: 10.1016/S2468-1253(19)30294-8. View

13.

Takahashi H, Cornish A, Sud A, Law P, Disney-Hogg L, Calvocoressi L . Mendelian randomization provides support for obesity as a risk factor for meningioma. Sci Rep. 2019; 9(1):309. PMC: 6343031. DOI: 10.1038/s41598-018-36186-6. View

14.

Quail D, Dannenberg A . The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2018; 15(3):139-154. PMC: 6374176. DOI: 10.1038/s41574-018-0126-x. View

15.

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-8. DOI: 10.1161/01.CIR.0000111245.75752.C6. View

16.

Winkler T, Gunther F, Hollerer S, Zimmermann M, Loos R, Kutalik Z . A joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implications. Nat Commun. 2018; 9(1):1946. PMC: 5956079. DOI: 10.1038/s41467-018-04124-9. View

17.

Henderson B, Feigelson H . Hormonal carcinogenesis. Carcinogenesis. 2000; 21(3):427-33. DOI: 10.1093/carcin/21.3.427. View

18.

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J . UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015; 12(3):e1001779. PMC: 4380465. DOI: 10.1371/journal.pmed.1001779. View

19.

Wu P, Gifford A, Meng X, Li X, Campbell H, Varley T . Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation. JMIR Med Inform. 2019; 7(4):e14325. PMC: 6911227. DOI: 10.2196/14325. View

20.

Locke A, Kahali B, Berndt S, Justice A, Pers T, Day F . Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015; 518(7538):197-206. PMC: 4382211. DOI: 10.1038/nature14177. View

21.

Hypponen E, Mulugeta A, Zhou A, Santhanakrishnan V . A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank. Lancet Digit Health. 2020; 1(3):e116-e126. DOI: 10.1016/S2589-7500(19)30028-7. View